HYSITE Latanoprost 50 microgram/mL eye drops bottle Australia - Inggris - Department of Health (Therapeutic Goods Administration)

hysite latanoprost 50 microgram/ml eye drops bottle

aspen pharmacare australia pty ltd - latanoprost, quantity: 50 microgram/ml - eye drops, solution - excipient ingredients: water for injections; sodium chloride; dibasic sodium phosphate; benzalkonium chloride; monobasic sodium phosphate monohydrate - reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.

LATANOPROST MEDIS latanoprost 50 micrograms/mL eye drops bottle Australia - Inggris - Department of Health (Therapeutic Goods Administration)

latanoprost medis latanoprost 50 micrograms/ml eye drops bottle

medis pharma pty ltd - latanoprost, quantity: 0.05 mg/ml - eye drops, solution - excipient ingredients: purified water; dibasic sodium phosphate dodecahydrate; sodium chloride; monobasic sodium phosphate dihydrate; benzalkonium chloride - latanoprost is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Latanoprost/Timolol CW 50/5 latanoprost 50 microgram/mL + timolol (as maleate) 5 mg/mL eye drop solution bottle Australia - Inggris - Department of Health (Therapeutic Goods Administration)

latanoprost/timolol cw 50/5 latanoprost 50 microgram/ml + timolol (as maleate) 5 mg/ml eye drop solution bottle

arrotex pharmaceuticals pty ltd - latanoprost, quantity: 50 microgram/ml; timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml) - eye drops, solution - excipient ingredients: dibasic sodium phosphate; monobasic sodium phosphate monohydrate; benzalkonium chloride; sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanoprost/timolol eye drops should not be used to initiate therapy.

CIP LATANOPROST latanoprost 50 microgram/mL eye drops bottle Australia - Inggris - Department of Health (Therapeutic Goods Administration)

cip latanoprost latanoprost 50 microgram/ml eye drops bottle

cipla australia pty ltd - latanoprost, quantity: 50 microgram/ml - eye drops - excipient ingredients: monobasic sodium phosphate monohydrate; water for injections; benzalkonium chloride; dibasic sodium phosphate; sodium chloride - reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

XALACOM latanoprost 50 microgram/mL, timolol (as maleate) 5 mg/mL eye drops Australia - Inggris - Department of Health (Therapeutic Goods Administration)

xalacom latanoprost 50 microgram/ml, timolol (as maleate) 5 mg/ml eye drops

aspen pharmacare australia pty ltd - latanoprost, quantity: 0.05 mg/ml; timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml) - eye drops, solution - excipient ingredients: hydrochloric acid; water for injections; sodium chloride; dibasic sodium phosphate; sodium hydroxide; benzalkonium chloride; monobasic sodium phosphate monohydrate - the reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. xalacom should not be used to initiate therapy.

Latanoprost 50 microgram/ml eye drops, solution Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

latanoprost 50 microgram/ml eye drops, solution

accord healthcare ireland ltd. - latanoprost - eye drops, solution - 50 microgram(s)/millilitre - prostaglandin analogues1); latanoprost

Latanoprost 50 microgram/ml eye drops, solution Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

latanoprost 50 microgram/ml eye drops, solution

actavis group ptc ehf - latanoprost - eye drops, solution - 50 microgram(s)/millilitre - prostaglandin analogues1); latanoprost

APOTEX-Latanoprost/Timolol 0.05/5 Eye drops latanoprost 50 ug/mL and timolol (as maleate) 5 mg/mL bottle Australia - Inggris - Department of Health (Therapeutic Goods Administration)

apotex-latanoprost/timolol 0.05/5 eye drops latanoprost 50 ug/ml and timolol (as maleate) 5 mg/ml bottle

arrotex pharmaceuticals pty ltd - latanoprost, quantity: 50 microgram/ml; timolol maleate, quantity: 5 mg/ml - eye drops, solution - excipient ingredients: monobasic sodium phosphate monohydrate; benzalkonium chloride; water for injections; dibasic sodium phosphate; hydrochloric acid; sodium chloride; sodium hydroxide - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanoprost/timolol eye drops should not be used to initiate therapy.

Xalatan 50 micrograms/ml eye drops, solution Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

xalatan 50 micrograms/ml eye drops, solution

ltt pharma limited - latanoprost - eye drops, solution - 50 microgram(s)/millilitre - prostaglandin analogues1); latanoprost - reduction of elevated intraocular pressure in patients with open angle glaucoma and ocular hypertension. reduction of elevated intraocular pressure in paediatric patients with elevated intraocular pressure and paediatric glaucoma

LATANOCOM latanoprost 50 microgram/mL, timolol (as maleate) 5 mg/mL eye drops Australia - Inggris - Department of Health (Therapeutic Goods Administration)

latanocom latanoprost 50 microgram/ml, timolol (as maleate) 5 mg/ml eye drops

aspen pharmacare australia pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); latanoprost, quantity: 0.05 mg/ml - eye drops, solution - excipient ingredients: sodium hydroxide; benzalkonium chloride; dibasic sodium phosphate; water for injections; sodium chloride; hydrochloric acid; monobasic sodium phosphate monohydrate - the reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanocom should not be used to initiate therapy.